Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
B Li, P Li, L Wei, J Zou, Y Wang, Q You… - Journal of Medicinal …, 2024 - ACS Publications
Rheumatoid arthritis (RA) is a chronic autoimmune disease. Targeting NLRP3
inflammasome, specifically its interaction with NEK7 via the LRR domain of NLRP3, is a …
inflammasome, specifically its interaction with NEK7 via the LRR domain of NLRP3, is a …
Therapeutic potential of targeting the NLRP3 inflammasome in rheumatoid arthritis
J Gao, H Zhang, Y Yang, J Tao - Inflammation, 2023 - Springer
NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is a
cytoplasmic multiprotein complex composed of the innate immune receptor protein NLRP3 …
cytoplasmic multiprotein complex composed of the innate immune receptor protein NLRP3 …
An RRx-001 analogue with potent anti-NLRP3 inflammasome activity but without high-energy nitro functional groups
NLRP3 inflammasome is involved in the pathology of multiple human inflammatory diseases
but there are still no clinically available medications targeting the NLRP3 inflammasome. We …
but there are still no clinically available medications targeting the NLRP3 inflammasome. We …
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor
The NLRP3 inflammasome plays a crucial role in innate immune-mediated inflammation
and contributes to the pathogenesis of multiple autoinflammatory, metabolic and …
and contributes to the pathogenesis of multiple autoinflammatory, metabolic and …
Recent progress on the discovery of NLRP3 inhibitors and their therapeutic potential
M Su, W Wang, F Liu, H Li - Current Medicinal Chemistry, 2021 - ingentaconnect.com
Background: Inflammation is the body's immune system's fast coordinating response to
irritants caused by pathogens, external injuries, and chemical or radiation effects. The …
irritants caused by pathogens, external injuries, and chemical or radiation effects. The …
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
H Jiang, H He, Y Chen, W Huang, J Cheng… - Journal of Experimental …, 2017 - rupress.org
The NLRP3 inflammasome has been implicated in the pathogenesis of a wide variety of
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …
The research progression of direct NLRP3 inhibitors to treat inflammatory disorders
X Chen, P Zhang, Y Zhang, M Wei, T Tian, D Zhu… - Cellular …, 2024 - Elsevier
The NLRP3 inflammasome represents a cytoplasmic multiprotein complex with the
capability to recognize a wide range of pathogen-derived, environmental, and endogenous …
capability to recognize a wide range of pathogen-derived, environmental, and endogenous …
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome
Inflammasomes are multiprotein complexes that drive inflammation and contribute to
protective immunity against pathogens and immune pathology in autoinflammatory …
protective immunity against pathogens and immune pathology in autoinflammatory …
Targeting the NLRP3 inflammasome in inflammatory diseases
MSJ Mangan, EJ Olhava, WR Roush… - Nature reviews Drug …, 2018 - nature.com
Danger signals are a hallmark of many common inflammatory diseases, and these stimuli
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …
NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases
V Ramalingam - Biochemical Pharmacology, 2023 - Elsevier
The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome has been
linked to the release of pro-inflammatory cytokines and is essential for innate defence …
linked to the release of pro-inflammatory cytokines and is essential for innate defence …
相关搜索
- lrr domain nlrp3 nek7
- lrr domain rheumatoid arthritis
- nlrp3 nek7 rheumatoid arthritis
- nlrp3 nek7 interaction
- lrr domain discovery and development
- nlrp3 nek7 discovery and development
- positive regulation rheumatoid arthritis
- nlrp3 inhibitor inflammatory diseases
- discovery and development rheumatoid arthritis
- therapeutic potential nlrp3 inflammasome
- lrr domain nlrp3 inhibitors
- nlrp3 inhibitors rheumatoid arthritis
- treatment of rheumatoid arthritis
- nlrp3 inhibitors discovery and development
- nlrp3 inflammasome in rheumatoid arthritis
- nlrp3 inhibitor inflammatory disorders